Publications of Udo Reichl
All genres
Journal Article (248)
1.
Journal Article
28 (4), 1843 (2023)
Reliable N-Glycan Analysis–Removal of Frequently Occurring Oligosaccharide Impurities by Enzymatic Degradation. Molecules 2.
Journal Article
Process intensification strategies toward cell culture‐based high‐yield production of a fusogenic oncolytic virus. Biotechnology and Bioengineering (2023)
3.
Journal Article
9 (1), 67 (2023)
Degradation Kinetics of Lignocellulolytic Enzymes in a Biogas Reactor Using Quantitative Mass Spectrometry. Fermentation 4.
Journal Article
106, pp. 4945 - 4961 (2022)
Cell-line screening and process development for a fusogenic oncolytic virus in small-scale suspension cultures. Applied Microbiology and Biotechnology 5.
Journal Article
15, 125 (2022)
Adaptation of a microbial community to demand-oriented biological methanation. Biotechnology for Biofuels and Bioproducts 6.
Journal Article
259, 104544 (2022)
Absolute quantification of viral proteins during single-round replication of MDCK suspension cells. Journal of Proteomics 7.
Journal Article
23 (2), e202100361 (2022)
Cell‐free multi‐enzyme synthesis and purification of uridine diphosphate galactose. ChemBioChem 8.
Journal Article
11 (22), 3634 (2022)
Human 3D Airway Tissue Models for Real-Time Microscopy: Visualizing Respiratory Virus Spreading. Cells 9.
Journal Article
10 (2), 249 (2022)
High-Titer Hepatitis C Virus Production in a Scalable Single-Use High Cell Density Bioreactor. Vaccines 10.
Journal Article
12 (3), 239 (2022)
Impact of Influenza A Virus Infection on Growth and Metabolism of Suspension MDCK Cells Using a Dynamic Model. Metabolites 11.
Journal Article
23 (16), 8841 (2022)
Discovering Biomarkers for Non-Alcoholic Steatohepatitis Patients with and without Hepatocellular Carcinoma Using Fecal Metaproteomics. International Journal of Molecular Sciences 12.
Journal Article
11 (5), 726 (2021)
Fecal Metaproteomics Reveals Reduced Gut Inflammation and Changed Microbial Metabolism Following Lifestyle-Induced Weight Loss. Biomolecules 13.
Journal Article
118 (10), pp. 3996 - 4013 (2021)
Towards integrated production of an influenza A vaccine candidate with MDCK suspension cells. Biotechnology and Bioengineering 14.
Journal Article
20 (20), 162 (2021)
Combining functional metagenomics and glycoanalytics to identify enzymes that facilitate structural characterization of sulfated N-glycans. Microbial Cell Factories 15.
Journal Article
342, pp. 139 - 148 (2021)
Continuous purification of influenza A virus particles using pseudo-affinity membrane chromatography. Journal of Biotechnology 16.
Journal Article
118 (12), pp. 4720 - 4734 (2021)
A high cell density perfusion process for Modified Vaccinia virus Ankara production: process integration with inline DNA digestion and cost analysis. Biotechnology and Bioengineering 17.
Journal Article
16 (1), e2000024 (2021)
Production of Modified Vaccinia Ankara Virus by Intensified Cell Cultures: A Comparison of Platform Technologies for Viral Vector Production. Biotechnology Journal 18.
Journal Article
19 (1), 91 (2021)
Cell culture-based production and in vivo characterization of purely clonal defective interfering influenza virus particles. BMC Biology 19.
Journal Article
105, pp. 7251 - 7264 (2021)
Cell culture–based production of defective interfering influenza A virus particles in perfusion mode using an alternating tangential flow filtration system. Applied Microbiology and Biotechnology 20.
Journal Article
105 (1), pp. 129 - 146 (2021)
OP7, a novel influenza A virus defective interfering particle: production, purification, and animal experiments demonstrating antiviral potential. Applied Microbiology and Biotechnology